SutroVax picks up $85 million in Series C round for pneumococcal vaccine
SutroVax, spun off from Sutro Biopharma, also announced a contract manufacturing deal with Swiss vendor Lonza.
SutroVax, spun off from Sutro Biopharma, also announced a contract manufacturing deal with Swiss vendor Lonza.